Literature DB >> 26426187

Repeated Burkholderia cepacia Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.

B L Apostolovic1,2, R M Velickovic-Radovanovic3,2, M R Andjelkovic-Apostolovic4, T P Cvetkovic3,2,5, M M Dinic3,6, J D Radivojevic2.   

Abstract

Burkholderia cepacia (B cepacia) is a rare opportunistic pathogen in continuous ambulatory peritoneal dialysis (CAPD) peritonitis. We describe the first case of repeated B cepacia CAPD peritonitis, occurring in an outpatient environment, treated with antimicrobial medication without peritoneal catheter removal. B cepacia may lead to repeat infection, therefore, we should insist on catheter removal during each peritonitis episode.

Entities:  

Year:  2015        PMID： 26426187      PMCID： PMC4763909          DOI： 10.7727/wimj.2014.278

Source DB:  PubMed          Journal:  West Indian Med J        ISSN： 0043-3144            Impact factor:   0.171


  14 in total

1.  Bacterial contamination of blood components due to Burkholderia cepacia contamination from clorhexidine bottles.

Authors:  J A García-Erce; J M Grasa; V M Solano; J J Gimeno; A López; M J Hernández; M L Marco; J L Arribas; M Giralt
Journal:  Vox Sang       Date:  2002-07       Impact factor: 2.144

2.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

Review 3.  The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation.

Authors:  Ludovic Vial; Annelise Chapalain; Marie-Christine Groleau; Eric Déziel
Journal:  Environ Microbiol       Date:  2010-09-29       Impact factor: 5.491

4.  Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit.

Authors:  M P Romero-Gómez; M I Quiles-Melero; P Peña García; A Gutiérrez Altes; M A García de Miguel; C Jiménez; Sylvia Valdezate; J A Sáez Nieto
Journal:  Infect Control Hosp Epidemiol       Date:  2008-04       Impact factor: 3.254

Review 5.  Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

Authors:  John E McGowan
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

Review 6.  Biofilms in peritoneal dialysis.

Authors:  M K Dasgupta; M Larabie
Journal:  Perit Dial Int       Date:  2001       Impact factor: 1.756

7.  Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand.

Authors:  Christopher E Pope; Patricia Short; Philip E Carter
Journal:  J Cyst Fibros       Date:  2010-09-15       Impact factor: 5.482

8.  Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis.

Authors:  Miguel Pérez Fontan; Ana Rodríguez-Carmona; Rafael García-Naveiro; Miguel Rosales; Pedro Villaverde; Francisco Valdés
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

9.  Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.

Authors:  Chun-Hsing Liao; Hou-Tai Chang; Chih-Cheng Lai; Yu-Tsung Huang; Meng-Shuian Hsu; Chia-Ying Liu; Chia-Jui Yang; Po-Ren Hsueh
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-09       Impact factor: 2.803

Review 10.  Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.

Authors:  E Mahenthiralingam; A Baldwin; C G Dowson
Journal:  J Appl Microbiol       Date:  2008-01-24       Impact factor: 3.772
View more
  1 in total

1.  Clinical and microbiological factors predicting outcomes of nonfermenting gram-negative bacilli peritonitis in peritoneal dialysis.

Authors:  Ana Claudia Moro Lima Dos Santos; Rodrigo Tavanelli Hernandes; Augusto Cezar Montelli; Aydir Cecília Marinho Monteiro; Thais Alves Barbosa; Carlos Henrique Camargo; Adriano Martison Ferreira; Alessandro Lia Mondelli; Maria de Lourdes Ribeiro de Souza da Cunha; Pasqual Barretti
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.